Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. The company's lead product candida...
FY 2025
Mar 5, 2026
Q4 2025
Q3 2025
Nov 6, 2025
Q2 2025
Aug 14, 2025
Q1 2025
May 15, 2025